Literature DB >> 23949354

Elective neck dissection for no neck during salvage total laryngectomy: findings, complications, and oncological outcome.

Naveed Basheeth1, Gerard O'Leary, Patrick Sheahan.   

Abstract

IMPORTANCE: Optimum management of the clinically negative neck in the presence of primary site recurrence of laryngeal or hypopharyngeal cancer remains unclear.
OBJECTIVE: To examine the incidence of occult cervical nodal metastatic disease in patients undergoing salvage laryngectomy with necks clinically staged as N0 at the time of recurrence and to define the role of elective neck dissection in this population with regard to risk of complications and oncologic outcomes.
DESIGN: Retrospective study of patients treated from 1996 through 2011.
SETTING: Academic teaching hospital. PARTICIPANTS: All patients undergoing salvage total laryngectomy for squamous cell carcinoma of larynx or hypopharynx after failed initial radiotherapy or chemoradiotherapy with radiographically N0 neck at time of recurrence. MAIN OUTCOMES AND MEASURES: Primary outcome measure was incidence of cervical nodal metastases detected by means of pathological examination of elective neck dissection specimens. Secondary outcome measures were incidence of major postoperative complications and regional cancer control.
RESULTS: Forty-five patients were included. Thirty-eight underwent elective unilateral (20) or bilateral (18) ND at the time of laryngectomy. Three patients (8%) had occult metastases (3 of 56 dissected heminecks [5%]). The incidence of major wound complications was significantly greater in patients undergoing bilateral ND (12 of 18 [67%]) than in patients undergoing unilateral or no ND (8 of 27 [30%]) (P = .03). There was no significant difference in regional control according to whether bilateral, unilateral, or no ND was performed. CONCLUSIONS AND RELEVANCE: The incidence of occult metastatic disease in N0 necks in patients undergoing salvage surgery after radiotherapy is low. Neck dissection in this population does not seem to have a significant impact on regional cancer control. The need for elective ND, particularly bilateral ND, should be balanced against possible increased risk of morbidity in this group.

Entities:  

Mesh:

Year:  2013        PMID: 23949354     DOI: 10.1001/jamaoto.2013.3995

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  16 in total

1.  Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Authors:  Soon-Hyun Ahn; Hyun Jun Hong; Soon Young Kwon; Kee Hwan Kwon; Jong-Lyel Roh; Junsun Ryu; Jun Hee Park; Seung-Kuk Baek; Guk Haeng Lee; Sei Young Lee; Jin Choon Lee; Man Ki Chung; Young Hoon Joo; Yong Bae Ji; Jeong Hun Hah; Minsu Kwon; Young Min Park; Chang Myeon Song; Sung-Chan Shin; Chang Hwan Ryu; Doh Young Lee; Young Chan Lee; Jae Won Chang; Ha Min Jeong; Jae-Keun Cho; Wonjae Cha; Byung Joon Chun; Ik Joon Choi; Hyo Geun Choi; Kang Dae Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2017-01-03       Impact factor: 3.372

2.  Completion Total Laryngectomy Ten Years After Near Total Laryngectomy for Radiorecurrent Cancer of the Glottis.

Authors:  Bipin T Varghese; Shirish Patil
Journal:  Indian J Surg Oncol       Date:  2018-08-09

3.  Elective neck treatment during salvage (pharyngo) laryngectomy.

Authors:  Simone E Bernard; Marjan H Wieringa; Cees A Meeuwis; Robert J Baatenburg de Jong; Aniel Sewnaik
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-01-04       Impact factor: 2.503

Review 4.  The development and treatment of periprosthetic leakage after prosthetic voice restoration. A literature review and personal experience part I: the development of periprosthetic leakage.

Authors:  Kai J Lorenz
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-11-18       Impact factor: 2.503

5.  Salvage total laryngectomy after external-beam radiotherapy: A 20-year experience.

Authors:  Vlad C Sandulache; Laura J Vandelaar; Heath D Skinner; Juan Cata; Katherine Hutcheson; Clifton David Fuller; Jack Phan; Zuhair Siddiqui; Stephen Y Lai; Randal S Weber; Mark E Zafereo
Journal:  Head Neck       Date:  2016-02-16       Impact factor: 3.147

6.  Elective Paratracheal Lymph Node Dissection in Salvage Laryngectomy.

Authors:  Janice L Farlow; Andrew C Birkeland; Andrew J Rosko; Kyle VanKoevering; Catherine T Haring; Joshua D Smith; J Chad Brenner; Andrew G Shuman; Steven B Chinn; Chaz L Stucken; Kelly M Malloy; Jeffrey S Moyer; Keith A Casper; Scott A McLean; Mark E P Prince; Carol R Bradford; Gregory T Wolf; Douglas B Chepeha; Matthew E Spector
Journal:  Ann Surg Oncol       Date:  2019-03-04       Impact factor: 5.344

Review 7.  Is elective neck dissection indicated during salvage surgery for head and neck squamous cell carcinoma?

Authors:  Alvaro Sanabria; Carl E Silver; Kerry D Olsen; Jesus E Medina; Marc Hamoir; Vinidh Paleri; Vanni Mondin; Alessandra Rinaldo; Juan P Rodrigo; Carlos Suárez; Carsten C Boedeker; Michael L Hinni; Luiz P Kowalski; Afshin Teymoortash; Jochen A Werner; Robert P Takes; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-02-11       Impact factor: 2.503

8.  Occult Nodal Disease Prevalence and Distribution in Recurrent Laryngeal Cancer Requiring Salvage Laryngectomy.

Authors:  Andrew C Birkeland; Andrew J Rosko; Mohamad R Issa; Andrew G Shuman; Mark E Prince; Gregory T Wolf; Carol R Bradford; Jonathan B McHugh; J Chad Brenner; Matthew E Spector
Journal:  Otolaryngol Head Neck Surg       Date:  2016-02-16       Impact factor: 3.497

9.  Elective neck dissection during salvage surgery after radiotherapy in patients with head and neck squamous cell carcinoma.

Authors:  G Pedemonte; E Esteller; J-C Villatoro; J-M Costa; C Valero; M Quer; X León
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-04       Impact factor: 2.124

Review 10.  Salvage surgery in post-chemoradiation laryngeal and hypopharyngeal carcinoma: outcome and review.

Authors:  L Putten; R Bree; P A Doornaert; J Buter; S E J Eerenstein; D H F Rietveld; D J Kuik; C R Leemans
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-06       Impact factor: 2.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.